FDA Tells Novartis That 'Facebook Sharing' Widget On Its Site Violates Drug Ad Rules

from the sharing-is-not-caring dept

Technology can certainly make for some interesting clashes with regulatory regimes. Social networking, for example, starts to bring up all sorts of questions about the fine line between certain regulated areas of advertising, and basic free speech communication issues. Eric Goldman points us to the news that the FDA is warning pharma giant Novartis (pdf) over its use of a “Facebook Share” widget on its site promoting the drug Tasigna (a leukemia drug).

The specific complaint is that the “share” feature includes promotional material about Tasigna, but not all of the associated risks (and, as with so many drugs, there’s quite a list of risks). Because of the limited amount of space often used in “sharing” content, the FDA feels that some of the sharing options are misleading, not correctly noting that the drug is only approved for some users.

The shared content is misleading because it makes representations about the efficacy of Tasigna but fails to communicate any risk information associated with the use of this drug. In addition, the shared content inadequately communicates Tasigna?s FDA-approved indication and implies superiority over other products. Thus, the shared content for Tasigna misbrands the drug in violation of the Federal Food, Drug, and Cosmetic Act (the Act) and FDA implementing regulations.

The FDA even picks on the specific word choices in some of the sharing features, such as calling the drug a “next-generation” drug, which apparently implies it’s better than other drugs in the space when that might not be the case. Advertising and marketing for pharmaceuticals has always been a contentious area, and I believe that many countries ban it, while the US allows it. But with the internet and social networking, the line between advertising and communication can start to blur. Yes, it may be problematic if Novartis is suggesting people “share” misleading or incomplete info about the drug, but what if people just start sharing that info on their own? Where do you draw the line?

Filed Under: , , ,
Companies: facebook, fda, novartis

Rate this comment as insightful
Rate this comment as funny
You have rated this comment as insightful
You have rated this comment as funny
Flag this comment as abusive/trolling/spam
You have flagged this comment
The first word has already been claimed
The last word has already been claimed
Insightful Lightbulb icon Funny Laughing icon Abusive/trolling/spam Flag icon Insightful badge Lightbulb icon Funny badge Laughing icon Comments icon

Comments on “FDA Tells Novartis That 'Facebook Sharing' Widget On Its Site Violates Drug Ad Rules”

Subscribe: RSS Leave a comment
11 Comments
Anonymous Coward says:

I think the line is when people start sharing on their own. At that point it goes from purposely misleading information to bad advice. Astroturfing does not count as “on their own”.

One reason is that a companies pitch is supposed to go to the world (or target group) at large (In clinical trials WONDEREX(TM) was reported to cause loss of teeth, numbness in limbs, and in some rare cases, death), while an individual’s advice is based off of their own anecdotal experience (WONDEREX(TM) didn’t make my teeth fall out).

Ron Rezendes (profile) says:

Re: Re:

“I think the line is when people start sharing on their own. At that point it goes from purposely misleading information to bad advice. Astroturfing does not count as “on their own”.”

That’s exactly where the line is drawn. However, I could see this scenario coming soon if it hasn’t already: where the people giving the “bad advice” are paid by the drug companies which is surely illegal, once they get caught.

Anonymous Coward says:

Re: Re:

Really?

Explain to us all why scientists used complete stranger to play a game of protein folding and publish the results were people were able to do better than the algorithms they had and explain why a social network dedicated to gather medical information on all diseases is putting out information that later is found to be true by other researchers noting that the guy’s doing the work are not scientists or medics just a bunch of people collecting and making sense of their own illnesses and therapies.

I think the people would be fine, they have the tools now to collect and process the information on a global scale and catch any misleading F.

Anonymous Coward says:

Re: Re:

The guy behind the social network talking about it.

http://www.ted.com/talks/jamie_heywood_the_big_idea_my_brother_inspired.html

The website.
http://www.patientslikeme.com/

Protein folding game.
http://fold.it/portal/

http://www.newscientist.com/article/mg20727725.100-computer-gamers-crack-proteinfolding-puzzle.html

The research done by scientists has named the players as co-authors of the paper, many of them are not scientists, but have one thing that all humans share, the ability to identify patterns.

Stuart says:

Re: Prescription drug advertising

I think prescription medication ads should be unmonitored. If someone wants to over rule their doctor because of an ad they saw while watching Big Brother. I say let them. If they did not research and then they start telling their doctor what they must have and their balls drop off I say that is a good thing. Helpful to humanity as a whole.

Add Your Comment

Your email address will not be published.

Have a Techdirt Account? Sign in now. Want one? Register here

Comment Options:

Make this the or (get credits or sign in to see balance) what's this?

What's this?

Techdirt community members with Techdirt Credits can spotlight a comment as either the "First Word" or "Last Word" on a particular comment thread. Credits can be purchased at the Techdirt Insider Shop »

Follow Techdirt

Techdirt Daily Newsletter

Techdirt Deals
Techdirt Insider Discord
The latest chatter on the Techdirt Insider Discord channel...
Loading...